These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 27164413)

  • 1. Plasma renin concentration represents an independent risk factor for mortality and is associated with liver dysfunction in patients with cirrhosis.
    Paternostro R; Reiberger T; Mandorfer M; Schwarzer R; Schwabl P; Bota S; Ferlitsch M; Trauner M; Peck-Radosavljevic M; Ferlitsch A
    J Gastroenterol Hepatol; 2017 Jan; 32(1):184-190. PubMed ID: 27164413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis.
    Bruha R; Jachymova M; Petrtyl J; Dvorak K; Lenicek M; Urbanek P; Svestka T; Vitek L
    World J Gastroenterol; 2016 Mar; 22(12):3441-50. PubMed ID: 27022226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
    Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A
    Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low 25-OH-vitamin D levels reflect hepatic dysfunction and are associated with mortality in patients with liver cirrhosis.
    Paternostro R; Wagner D; Reiberger T; Mandorfer M; Schwarzer R; Ferlitsch M; Trauner M; Peck-Radosavljevic M; Ferlitsch A
    Wien Klin Wochenschr; 2017 Jan; 129(1-2):8-15. PubMed ID: 27888359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of transient elastography with hepatic venous pressure gradient in patients with cirrhotic portal hypertension: A study of 326 patients from India.
    Kumar A; Khan NM; Anikhindi SA; Sharma P; Bansal N; Singla V; Arora A
    World J Gastroenterol; 2017 Jan; 23(4):687-696. PubMed ID: 28216976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
    Kim MY; Baik SK; Suk KT; Yea CJ; Lee IY; Kim JW; Cha SH; Kim YJ; Um SH; Han KH
    Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertension.
    Semmler G; Simbrunner B; Scheiner B; Schwabl P; Paternostro R; Bucsics T; Stättermayer AF; Bauer D; Pinter M; Ferenci P; Trauner M; Mandorfer M; Reiberger T
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2164-2172. PubMed ID: 31062417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis.
    Rincón D; Lo Iacono O; Tejedor M; Hernando A; Ripoll C; Catalina MV; Salcedo M; Matilla A; Senosiain M; Clemente G; Molinero LM; Albillos A; Bañares R
    Scand J Gastroenterol; 2013 Apr; 48(4):487-95. PubMed ID: 22871085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test.
    Hametner S; Ferlitsch A; Ferlitsch M; Etschmaier A; Schöfl R; Ziachehabi A; Maieron A
    PLoS One; 2016; 11(2):e0149230. PubMed ID: 26895398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of portal hypertension by real-time shear wave elastography in cirrhotic patients.
    Kim TY; Jeong WK; Sohn JH; Kim J; Kim MY; Kim Y
    Liver Int; 2015 Nov; 35(11):2416-24. PubMed ID: 25875718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Nogo-A and placental growth factor levels are associated with portal hypertension in patients with liver cirrhosis.
    Gelman S; Salteniene V; Pranculis A; Skieceviciene J; Zykus R; Petrauskas D; Kupcinskas L; Canbay A; Link A; Kupcinskas J
    World J Gastroenterol; 2019 Jun; 25(23):2935-2946. PubMed ID: 31249451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of sarcopenia on prognostic value of cirrhosis: going beyond the hepatic venous pressure gradient and MELD score.
    Kang SH; Jeong WK; Baik SK; Cha SH; Kim MY
    J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):860-870. PubMed ID: 30371017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of early portal hypertension with routine data and liver stiffness in patients with asymptomatic liver disease: a prospective study.
    Augustin S; Millán L; González A; Martell M; Gelabert A; Segarra A; Serres X; Esteban R; Genescà J
    J Hepatol; 2014 Mar; 60(3):561-9. PubMed ID: 24211744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of hepatic venous pressure gradient for in-hospital mortality of patients with severe acute alcoholic hepatitis.
    Rincon D; Lo Iacono O; Ripoll C; Gomez-Camarero J; Salcedo M; Catalina MV; Hernando A; Clemente G; Matilla A; Nuñez O; Bañares R
    Aliment Pharmacol Ther; 2007 Apr; 25(7):841-8. PubMed ID: 17373923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baroreceptor sensitivity and baroreceptor effectiveness index in cirrhosis: the relevance of hepatic venous pressure gradient.
    Genovesi S; Prata Pizzala DM; Pozzi M; Ratti L; Milanese M; Vincenti A; Stella A; Mancia G
    Liver Int; 2010 Feb; 30(2):232-9. PubMed ID: 19793198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The New Cutoff Value of the Hepatic Venous Pressure Gradient on Predicting Long-Term Survival in Cirrhotic Patients.
    Kim TY; Suk KT; Jeong SW; Ryu T; Kim DJ; Baik SK; Sohn JH; Jeong WK; Choi E; Jang JY; Kim MY
    J Korean Med Sci; 2019 Aug; 34(33):e223. PubMed ID: 31436052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria.
    Merkel C; Bolognesi M; Berzigotti A; Amodio P; Cavasin L; Casarotto IM; Zoli M; Gatta A
    J Hepatol; 2010 Jan; 52(1):45-53. PubMed ID: 19914730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of hepatic venous pressure gradient and endoscopic grading of esophageal varices.
    Lee E; Kim YJ; Goo DE; Yang SB; Kim HJ; Jang JY; Jeong SW
    World J Gastroenterol; 2016 Mar; 22(11):3212-9. PubMed ID: 27003998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis.
    Boleslawski E; Petrovai G; Truant S; Dharancy S; Duhamel A; Salleron J; Deltenre P; Lebuffe G; Mathurin P; Pruvot FR
    Br J Surg; 2012 Jun; 99(6):855-63. PubMed ID: 22508371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.